ESMO 2023: Highlights on belzutifan in previously treated advanced clear cell RCC: The LITESPARK-005 study
Share.
About Author
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
